Patents by Inventor Xueyun Gao

Xueyun Gao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS INFECTION
    Publication number: 20230241101
    Abstract: Provided is a therapeutic composition for treatment of coronavirus infection. The therapeutic composition contains a gold compound that generates Au—S bonds at the active pockets of the main protease of the virus while suppressing the virus-induced inflammations in the body.
    Type: Application
    Filed: May 20, 2021
    Publication date: August 3, 2023
    Applicant: BEIJING BJUT SCIENCE AND TECHNOLOGY PARK CO., LTD
    Inventor: Xueyun GAO
  • Therapeutic Agents for Treatment of Coronavirus Infection
    Publication number: 20210369770
    Abstract: A therapeutic composition for treatment of coronavirus infections. The therapeutic composition contains a gold compound effective for Rheumatoid Arthritis treatment that both generates gold-S bonds at the active pockets of the main protease of the virus and suppresses the virus induced inflammations in the body.
    Type: Application
    Filed: February 22, 2021
    Publication date: December 2, 2021
    Inventor: Xueyun Gao
  • A Method for Mitigating Osteoporosis Using Metallic Gold Cluster Molecules
    Publication number: 20180207289
    Abstract: A therapeutic method for mitigating bone loss. This method includes preparing and administering to animals intraperitoneally or orally a therapeutic agent containing metallic gold cluster molecules as an active ingredient.
    Type: Application
    Filed: March 10, 2017
    Publication date: July 26, 2018
    Inventor: Xueyun Gao
  • Method for mitigating osteoporosis using metallic gold cluster molecules
    Patent number: 10029019
    Abstract: A therapeutic method for mitigating bone loss. This method includes preparing and administering to animals intraperitoneally or orally a therapeutic agent containing metallic gold cluster molecules as an active ingredient.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: July 24, 2018
    Inventor: Xueyun Gao
  • Metallic gold cluster molecules as therapeutic agents for arthritic animals
    Patent number: 9993562
    Abstract: A therapeutic method for attenuating symptoms of inflammation and autoimmune diseases. This method includes preparing and administering to animals intraperitoneally or orally a metallic gold cluster complex preparation.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: June 12, 2018
    Inventor: Xueyun Gao
  • Metallic Gold Cluster Molecules As Therapeutic Agents for Arthritic Animals
    Publication number: 20170304408
    Abstract: A therapeutic method for attenuating symptoms of inflammation and autoimmune diseases. This method includes preparing and administering to animals intraperitoneally or orally a metallic gold cluster complex preparation.
    Type: Application
    Filed: April 22, 2016
    Publication date: October 26, 2017
    Inventor: Xueyun Gao
  • Peptide-bound gold metal nano-clusters as cancer cell killing agents
    Patent number: 9090660
    Abstract: Peptide-bound gold metal nanocluster complexes are produced to induce cancer cell death by dramatically inhibiting TrxR activities of the cancer cells. Specificity is shown by selectively designing peptide sequences.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: July 28, 2015
    Inventor: Xueyun Gao
  • Peptide-Bound Gold Metal Nano-clusters as Cancer Cell Killing Agents
    Publication number: 20140256038
    Abstract: Peptide-bound gold metal nanocluser complexes are produced to induce cancer cell death by dramatically inhibiting TrxR activities of the cancer cells. Specificity is shown by selectively designing peptide sequences.
    Type: Application
    Filed: March 7, 2013
    Publication date: September 11, 2014
    Inventor: Xueyun Gao
  • Selenium nanoparticles with improved biological effects
    Patent number: 8445026
    Abstract: Novel methods for biological effective, stable amorphous and monoclinic selenium nanoparticles are disclosed. They are prepared by reacting selenium source with a reducing agent or an oxidative agent in an aqueous media at a temperature between 0-100° C. in the presence of selenium binding polymer molecules such as poly/oligopeptide acids or peptone or nucleic acids or poly/oligosaccharide or their mixtures.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: May 21, 2013
    Inventors: Xueyun Gao, Yi Sun
  • Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof
    Patent number: 8383919
    Abstract: A method of one reaction step for synthesis of peptide template fluorescent metal nanoclusters as bioprobes. Specific targeting peptide containing a metal reactive group is synthesized and used to react with a metal salt solution under a sufficient pH condition at room temperature in forming peptide template fluorescent metal nanoclusters. The dialyzed metal nanoclusters is used directly as bio-probes.
    Type: Grant
    Filed: January 22, 2011
    Date of Patent: February 26, 2013
    Inventor: Xueyun Gao
  • Selenium Nanoparticles with Improvded Biological Effects
    Publication number: 20120207846
    Abstract: Novel methods for biological effective, stable amorphous and monoclinic selenium nanoparticles are disclosed. They are prepared by reacting selenium source with a reducing agent or an oxidative agent in an aqueous media at a temperature between 0-100° C. in the presence of selenium binding polymer molecules such as poly/oligopeptide acids or peptone or nucleic acids or poly/oligosaccharide or their mixtures.
    Type: Application
    Filed: November 21, 2008
    Publication date: August 16, 2012
    Inventors: Xueyun GAO, Yi SUN
  • SELENIUM NANOPARTICLES WITH IMPROVED BIOLOGICAL EFFECTS
    Publication number: 20120202062
    Abstract: Novel methods for biological effective, stable amorphous and monoclinic selenium nanoparticles are disclosed. They are prepared by reacting selenium source with a redox agent in an aqueous media at a temperature between 0-100° C. in the presence of nucleic acids or poly/oligosaccharide or their mixtures.
    Type: Application
    Filed: August 10, 2011
    Publication date: August 9, 2012
    Inventor: Xueyun Gao
  • Treatment of Cancer with Selenium Nanoparticles
    Publication number: 20110262564
    Abstract: Novel chemopreventive and chemotherapeutic cancer treatment method using elemental selenium nanoparticles. Cancer cells, especially androgen dependent prostate cancers are exposed to selenium from elemental selenium nanoparticle treatment, and apoptosis is induced in the cancer cells.
    Type: Application
    Filed: June 18, 2010
    Publication date: October 27, 2011
    Inventors: Xueyun Gao, Ling Kong
  • Synthesis of Highly Fluorescent Peptide-Metallic Nanoclusters as Bio-probes
    Publication number: 20110118441
    Abstract: A method of one reaction step for synthesis of peptide template fluorescent metal nanoclusters as bioprobes. Specific targeting peptide containing a metal reactive group is synthesized and used to react with a metal salt solution under a sufficient pH condition at room temperature in forming peptide template fluorescent metal nanoclusters. The dialyzed metal nanoclusters is used directly as bio-probes.
    Type: Application
    Filed: January 22, 2011
    Publication date: May 19, 2011
    Inventor: Xueyun Gao